It was reported that resolute integrity rx drug eluting stents were used as part of a study evaluating the safety and efficacy outcomes after primary pci in patients enrolled in the dapt-stemi trial.998 patients received the resolute integrity stents.Adverse events reported at 30 days and 6 month follow up included all-cause death (8 patients died, seven of which were cardiac deaths), mi, revascularization, stroke and timi major bleeding was respectively 8 (0.8%), 9 (0.8%), 34 (3.4%), 2 (0.2%), and 4 (0.4%).The rate of target lesion revascularizations involving the culprit lesion was 1.1%.Target lesion failure was 1.5%.The rate of definite st was 0.5%.The rate of both definite or probable st was 0.7%.
|